Source-grounded facts extracted from Trulieve Cannabis Corp.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Jason Pernell resigned as President at Trulieve Cannabis Corp..
“On June 11, 2026 (the “Termination Date”), the Company and Jason Pernell mutually agreed that Mr. Pernell shall terminate his employment his position of President of Trulieve Cannabis Corp. (the “Company”) effective immediately.”
Trulieve Cannabis Corp. shareholders approved To ratify the selection of WithumSmith+Brown, PC as auditors for the Company for the year ending December 31, 2026 at the 2026-12-31 meeting.
“Proposal No. 4: To ratify the selection by the Audit Committee of the Board of WithumSmith+Brown, PC as auditors for the Company for the year ending December 31, 2026. The shareholders ratified the appointment of WithumSmith+Brown, PC as the Company’s independent registered public accounting firm for the ensuing fiscal year ending December 31, 2026. Votes For Votes Against Abstain 107,441,983 1,169,382 676,220”
Trulieve Cannabis Corp. shareholders approved Advisory vote on the compensation of the Company’s named executive officers at the 2025-12-31 meeting.
“Proposal No. 3: To conduct a non-binding advisory vote on the compensation of the Company’s named executive officers. The shareholders approved the compensation paid to the Company’s named executive officers for the fiscal year ending December 31, 2025. Votes For Votes Against Abstain Broker Non-Votes 49,752,239 1,997,073 333,090 57,205,183”
Trulieve Cannabis Corp. shareholders approved To elect seven directors as directors of the Company for the forthcoming year.
“Proposal No. 2: To elect seven directors as directors of the Company for the forthcoming year. The shareholders voted to elect the following individuals as directors of the Company until the next annual meeting of shareholders at which election of directors is considered, or until his or her successor is duly elected or appointed:”
Trulieve Cannabis Corp. shareholders approved To set the number of directors of the Company at seven.
“Proposal No. 1: To set the number of directors of the Company at seven (7) Votes For Votes Against Abstain 107,646,420 1,235,766 405,399”
Trulieve Cannabis Corp. reported first quarter ended March 31, 2026 results: revenue $287 million, net income $2 million.
“as Exhibit 99.1. --- EX-99.1 (EX-99.1) --- Trulieve Reports Profitable First Quarter 2026 Results Bolstered by Margins and Cash Flow Generation • First quarter revenue of $287 million, with 59% gross margin • Positive net income of $2 million and Adjusted EBITDA of $100 million* • Rescheduling of medical marijuana to Schedule III enabled applications for DEA”
Trulieve Cannabis Corp. incurred senior notes of U.S. $60 million aggregate principal amount at 10.5% per annum maturing December 17, 2030.
“On January 29, 2026, Trulieve Cannabis Corp. (the “Company”) issued an additional U.S. $60 million aggregate principal amount of its 10.5% senior secured notes due December 17, 2030 (the “Additional Notes”).”
Trulieve Cannabis Corp. entered into Indenture with Odyssey Trust Company valued at U.S. $60 million aggregate principal amount (effective 2026-01-29).
“On January 29, 2026, Trulieve Cannabis Corp. (the “Company”) issued an additional U.S. $60 million aggregate principal amount of its 10.5% senior secured notes due December 17, 2030 (the “Additional Notes”).”
Trulieve Cannabis Corp. entered into Indenture with Odyssey Trust Company valued at $140,000,000 aggregate principal amount (effective 2025-12-17).
“On December 17, 2025, Trulieve Cannabis Corp. (the “Company”) issued $140,000,000 aggregate principal amount of its 10.5% senior secured notes due December 17, 2030 (the “Notes”). The Notes were issued under an indenture dated as of June 18, 2019, as supplemented by a second supplemental indenture dated as of December 17, 2025 (the “Indenture”) by and among the Company and Odyssey Trust Company, as trustee (the “Trustee”).”
Trulieve Cannabis Corp. incurred senior notes of $140,000,000 aggregate principal amount with Odyssey Trust Company at 10.5% maturing December 17, 2030.
“On December 17, 2025, Trulieve Cannabis Corp. (the “Company”) issued $140,000,000 aggregate principal amount of its 10.5% senior secured notes due December 17, 2030 (the “Notes”).”
Ryan Blust was appointed as Interim Chief Financial Officer at Trulieve Cannabis Corp..
“The Company has appointed Ryan Blust, the Company’s Vice President, Finance, as its interim Chief Financial Officer, effective immediately.”
Wes Getman resigned as Chief Financial Officer at Trulieve Cannabis Corp..
“On March 6, 2025, Wes Getman resigned from his position as Chief Financial Officer of Trulieve Cannabis Corp. (the “Company”) to pursue other opportunities.”
Trulieve Cannabis Corp. reported the quarter ended March 31, 2024 results: revenue $298 million, net income net loss of $23 million.
“--- tcnnf-2024xq1xexx991 Exhibit 99.1 Trulieve Reports First Quarter 2024 Results Demonstrating Core Business Strength and Cash Generation • First quarter performance of $298 million in revenue, up 4% sequentially, and 58% gross margin • Strong cash flow from operations of $139 million and free cash flow of $124 million* in Q1 2024 • Definitive progress made”
Giannella Alvarez departed as Director at Trulieve Cannabis Corp..
“On April 17, 2024, Giannella Alvarez gave notice that she will not be standing for reelection to the board of directors at the annual general and special meeting of the shareholders of Trulieve Cannabis Corp. (the "Company") to be held June 12, 2024.”
Trulieve Cannabis Corp. engaged WithumSmith+Brown, PC as its auditor.
“On March 25, 2024, the Audit Committee of the Company approved the appointment of WithumSmith+Brown, PC (“Withum”) as the Company’s independent registered public accounting firm for the fiscal year ended December 31, 2024.”
Trulieve Cannabis Corp. dismissed Marcum LLP as its auditor.
“Effective March 25, 2024, the audit committee of the Board of Directors (the "Audit Committee") of Trulieve Cannabis Corp. (the "Company") approved the dismissal of Marcum LLP ("Marcum") as the Company’s independent registered public accounting firm and informed Marcum of such dismissal.”
Marie Zhang was appointed as Chief Operating Officer at Trulieve Cannabis Corp..
“On January 12, 2024, Trulieve Cannabis Corp. (the “Company”) announced the appointment of Marie Zhang as the Company’s Chief Operating Officer, effective January 29, 2024.”
Ryan Blust changed role as Vice President, Finance at Trulieve Cannabis Corp..
“Ryan Blust will no longer serve as Interim Chief Financial Officer but will remain as the Company’s Vice President, Finance.”
Wes Getman was appointed as Chief Financial Officer at Trulieve Cannabis Corp..
“On December 22, 2023, Trulieve Cannabis Corp. (the “Company”) announced the appointment of Wes Getman as the Company’s Chief Financial Officer, effective January 1, 2024.”
Trulieve Cannabis Corp. reported the quarter ended September 30, 2023 results: revenue $275 million, net income net loss of $25 million. Guidance raised.
“Generally Accepted Accounting Principles unless otherwise indicated. Numbers may not sum perfectly due to rounding. Q3 2023 Financial and Operational Highlights* • Revenue of $275 million, with 96% of revenue from retail sales. • Achieved GAAP gross margin of 52%, with gross profit of $143 million. • SG&A expenses lowered by $2 million sequentially to $94 million.”
Trulieve Cannabis Corp. reported for the quarter ended June 30, 2023 results: revenue Revenue of $282 million, net income Reported net loss of $404 million.
“Generally Accepted Accounting Principles unless otherwise indicated. Numbers may not sum perfectly due to rounding. Q2 2023 Financial and Operational Highlights* • Revenue of $282 million, with 96% of revenue from retail sales. Excluding deferred revenue, retail revenue increased by $3 million sequentially driven by increased traffic and volume partly offset by”
Ryan Blust was appointed as Interim Chief Financial Officer at Trulieve Cannabis Corp..
“The Company has appointed Ryan Blust, the Company’s Vice President, Finance, as its interim Chief Financial Officer, effective immediately.”
Tim Mullany resigned as Chief Financial Officer at Trulieve Cannabis Corp..
“On July 21, 2023, Trulieve Cannabis Corp. (the “Company”) announced the departure of Tim Mullany as Chief Financial Officer, for personal reasons and effective July 20, 2023.”
Trulieve Cannabis Corp. shareholders approved To ratify the selection by the Audit Committee of the Board of Marcum LLP as auditors for the Company for the year ending December 31, 2023. at the 2023-06-20 meeting.
“Proposal No. 5: To ratify the selection by the Audit Committee of the Board of Marcum LLP as auditors for the Company for the year ending December 31, 2023. The shareholders ratified the appointment of Marcum LLP as the Company's independent registered public accounting firm for the ensuing fiscal year ending December 31, 2023. Votes For Votes Against Abstain Broker Non-Votes 104,226,751 2,007,542 3,803,648 —”
Trulieve Cannabis Corp. shareholders approved To approve the amendment and restatement of the Company's 2021 Omnibus Incentive Plan. at the 2023-06-20 meeting.
“Proposal No. 4: To approve the amendment and restatement of the Company's 2021 Omnibus Incentive Plan. The shareholders approved the amendment and restatement of the Company's 2021 Omnibus Incentive Plan. Votes For Votes Against Abstain Broker Non-Votes 60,053,253 14,418,151 474,994 35,091,543”
Trulieve Cannabis Corp. shareholders approved To conduct a non-binding advisory vote on the compensation of the Company's named executive officers. at the 2023-06-20 meeting.
“Proposal No. 2: To conduct a non-binding advisory vote on the compensation of the Company's named executive officers. The shareholders approved the compensation paid to the Company's named executive officers for the fiscal year ending December 31, 2022. Votes For Votes Against Abstain Broker Non-Votes 59,605,621 11,391,424 3,949,353 35,091,543”
Trulieve Cannabis Corp. shareholders approved To elect eight directors as directors of the Company for the forthcoming year. at the 2023-06-20 meeting.
“The shareholders voted to elect the following individuals as directors of the Company until the next annual meeting of shareholders at which election of directors is considered, or until his or her successor is duly elected or appointed: Name of Director Nominee Votes For Votes Withheld Broker Non-Votes Giannella Alvarez 73,450,949 1,495,449 35,091,543 Thad Beshears 73,314,778 1,631,620 35,091,543 Peter Healy 73,205,174 1,741,224 35,091,543 Richard May 73,370,399 1,575,999 35,091,543 Thomas Millner 73,325,750 1,620,648 35,091,543 Jane Morreau 73,206,664 1,739,734 35,091,543 Kim Rivers 72,058,794 2,887,604 35,091,543 Susan Thronson 70,322,175 4,624,223 35,091,543”
Ryan Blust was appointed as Interim Chief Financial Officer at Trulieve Cannabis Corp..
“the Company has appointed Ryan Blust, the Company’s Vice President, Finance, to serve as its Interim Chief Financial Officer, effective immediately”
Timothy Mullany was appointed as Chief Financial Officer at Trulieve Cannabis Corp..
“the Company appointed Timothy Mullany as its Chief Financial Officer, effective as of July 10, 2023”
Alex D'Amico resigned as Chief Financial Officer at Trulieve Cannabis Corp..
“Mr. D’Amico’s resignation as Chief Financial Officer was effective immediately.”
Trulieve Cannabis Corp. reported first quarter ended March 31, 2023 results: revenue $289 million, net income net loss of $64 million.
“Revenue of $289 million, with 95% of revenue from retail sales.”
Joy Malivuk was appointed as Vice President, Chief Accounting Officer at Trulieve Cannabis Corp..
“On April 26, 2023, Joy Malivuk, age 48, was appointed as the Vice President, Chief Accounting Officer of Trulieve Cannabis Corp. (the “Company”).”
Trulieve Cannabis Corp. reported fourth quarter and year ended December 31, 2022 results: revenue $302 million, net income net loss of $77 million.
“Fourth Quarter and Record Full Year 2022 Results Exceeding $1.2 Billion in Revenue • Record revenue of $1.24 billion in 2022, up 32% year over year, and quarterly revenue of $302 million, with 2% retail revenue growth sequentially • Industry leading U.S. retail network of 181 dispensaries, up 14% from 2021, supported by over 4 million square feet of cultivation”
Rebecca L. Young resigned as Vice President, Chief Accounting Officer at Trulieve Cannabis Corp..
“On January 10, 2023, Rebecca L. Young, Vice President, Chief Accounting Officer of Trulieve Cannabis Corp. (the “Company”) gave notice of her resignation to be effective as of March 10, 2023 in order to pursue other opportunities.”
Trulieve Cannabis Corp. incurred loan of Seventy-One Million Five Hundred Thousand Dollars ($71,500,000) with Valley National Bank at 7.53% fixed maturing December 21, 2027.
“On December 21, 2022, Trulieve Capps Highway LLC (the “Borrower”), a wholly-owned subsidiary of Trulieve Cannabis Corp. (the “Company”), entered into a loan agreement (the “Loan Agreement”) with Valley National Bank, as agent, and the lenders named therein, for a commercial loan of Seventy-One Million Five Hundred Thousand Dollars ($71,500,000) (the “Loan”). The Loan is secured by a mortgage on the Borrower’s real property located at 1834 W. Capps Highway, Monticello, Florida. The proceeds of the Loan are expected to be used general corporate purposes. The Company will pay interest at a fixed rate of 7.53% for the duration of the five year loan, which matures on December 21, 2027.”
Trulieve Cannabis Corp. entered into Loan Agreement with Valley National Bank, as agent, and the lenders named therein valued at Seventy-One Million Five Hundred Thousand Dollars ($71,500,000) (effective 2022-12-21).
“On December 21, 2022, Trulieve Capps Highway LLC (the “Borrower”), a wholly-owned subsidiary of Trulieve Cannabis Corp. (the “Company”), entered into a loan agreement (the “Loan Agreement”) with Valley National Bank, as agent, and the lenders named therein, for a commercial loan of Seventy-One Million Five Hundred Thousand Dollars ($71,500,000) (the “Loan”).”
Trulieve Cannabis Corp. reported financial results for three and nine months ended September 30, 2022.
“On November 9, 2022, Trulieve Cannabis Corp. (the “Company”) announced via press release its results for the three and nine months ended September 30, 2022. A copy of the Company’s press release is hereby furnished to the Commission and incorporated herein by reference as Exhibit 99.1.”
Kim Rivers changed role as President at Trulieve Cannabis Corp..
“Ms. Rivers ceased serving as President of the Company in December 2021 upon the appointment of Mr. White as President.”
Kim Rivers changed role as President at Trulieve Cannabis Corp..
“Kim Rivers, the Company’s Chief Executive Officer and principal executive officer, will no longer serve as President of the Company as of the Effective Date.”
Steven M. White was appointed as President at Trulieve Cannabis Corp..
“On December 24, 2021 (the “Effective Date”), the Board of Directors of Trulieve Cannabis Corp. (the “Company”) appointed Steven M. White as President of the Company.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.